Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03111537 · ClinicalTrials.gov registry record · NA

Methods Project 4: Clinical Trial - Amended

A NA study of Tobacco Smoking, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
264
Enrollment target
3
Study locations

NCT03111537 is a NA study of Tobacco Smoking that has completed, run by University of Minnesota. The registered enrollment target is 264 participants, below the 470-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (44% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03111537, a NA study of Tobacco Smoking, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
264 participants
Enrollment target
3
Study locations

Study Summary

Cigarette smokers will be randomized to E-cigarette, Nicotine Gum or Lozenge, or Control Group. Participants will enter a 1 week sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a 2 week baseline assessment phase and will then enter an 8 week intervention. Tobacco use patterns, subjective responses to product, and nicotine and toxicant exposure will be assessed.

Conditions Studied

Interventions

  • OTHER Cigarettes
  • OTHER E-Cigarette
  • OTHER Nicotine Gum or Lozenge

Study Locations (3)

Minnesota

  • Masonic Cancer Center, University of Minnesota - Minneapolis

New York

  • Roswell Park Cancer Center - Buffalo

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 264 participants
Start Date 2015-05
Est. Completion 2018-02
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT03111537

The ClinicalTrials.gov registry entry for NCT03111537 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 470-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (44% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Smoking appearing as the primary indexed condition, and to 3 interventions - of which Cigarettes is the first listed.

NCT03111537 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Minnesota, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT03111537 about?

NCT03111537 is a clinical study titled "Methods Project 4: Clinical Trial - Amended". Cigarette smokers will be randomized to E-cigarette, Nicotine Gum or Lozenge, or Control Group. Participants will enter a 1 week sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a 2 week baseline assessment phase and will then enter an 8 week inte...

What is the current status of trial NCT03111537?

This trial is currently completed. It is a NA study. The enrollment target is 264 participants. The study started on 2015-05. Estimated completion is 2018-02.

What conditions does trial NCT03111537 study?

This clinical trial studies the following conditions: Tobacco Smoking.

What interventions are being tested in trial NCT03111537?

The interventions under investigation include: Cigarettes (OTHER), E-Cigarette (OTHER), Nicotine Gum or Lozenge (OTHER).

Who is sponsoring clinical trial NCT03111537?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03111537 being conducted?

This trial has 3 study locations across Minnesota, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.